GB0912160D0 - Polymer modified macromolecules - Google Patents
Polymer modified macromoleculesInfo
- Publication number
- GB0912160D0 GB0912160D0 GBGB0912160.9A GB0912160A GB0912160D0 GB 0912160 D0 GB0912160 D0 GB 0912160D0 GB 0912160 A GB0912160 A GB 0912160A GB 0912160 D0 GB0912160 D0 GB 0912160D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- polymer modified
- modified macromolecules
- polymer
- macromolecules
- biological macromolecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/585—Calcitonins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to processes and compounds for adding a polymer to a biological macromolecule, wherein the biological macromolecule comprises a sulphydryl group or disulphide bond which is reacted with a vinyl moiety attached to the polymer.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0912160.9A GB0912160D0 (en) | 2009-07-13 | 2009-07-13 | Polymer modified macromolecules |
PCT/GB2010/001338 WO2011007133A2 (en) | 2009-07-13 | 2010-07-13 | Polymer modified macromolecules |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0912160.9A GB0912160D0 (en) | 2009-07-13 | 2009-07-13 | Polymer modified macromolecules |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0912160D0 true GB0912160D0 (en) | 2009-08-26 |
Family
ID=41057882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0912160.9A Ceased GB0912160D0 (en) | 2009-07-13 | 2009-07-13 | Polymer modified macromolecules |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0912160D0 (en) |
WO (1) | WO2011007133A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110095800A (en) | 2010-02-19 | 2011-08-25 | 삼성전자주식회사 | Method and apparatus for transmitting video content compressed by a codec |
CN111318185B (en) * | 2018-12-17 | 2022-04-05 | 中国石油化工股份有限公司 | Coating process of graphene filter membrane material with enhanced hydrophilicity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763548A (en) | 1995-03-31 | 1998-06-09 | Carnegie-Mellon University | (Co)polymers and a novel polymerization process based on atom (or group) transfer radical polymerization |
US5807937A (en) | 1995-11-15 | 1998-09-15 | Carnegie Mellon University | Processes based on atom (or group) transfer radical polymerization and novel (co) polymers having useful structures and properties |
CA2258006C (en) | 1996-06-12 | 2008-07-29 | University Of Warwick | Polymerisation catalyst and process |
GB0314472D0 (en) | 2003-06-20 | 2003-07-23 | Warwick Effect Polymers Ltd | Polymer |
AU2007226348A1 (en) | 2006-03-10 | 2007-09-20 | Warwick Effect Polymers Ltd. | Polymers |
-
2009
- 2009-07-13 GB GBGB0912160.9A patent/GB0912160D0/en not_active Ceased
-
2010
- 2010-07-13 WO PCT/GB2010/001338 patent/WO2011007133A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011007133A2 (en) | 2011-01-20 |
WO2011007133A3 (en) | 2011-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1211280A1 (en) | Process for the praparation of 2,3,3,3-tetrafluoropropene 2333- | |
BR112013000616A2 (en) | polymer grafted by nitrogen associative molecules | |
EP2399940A3 (en) | Modified macromolecules and methods of making and using thereof | |
MX349674B (en) | Terminal-modified difunctional sulfur-containing polymers, compositions thereof and methods of use. | |
MX2010009154A (en) | Conjugated factor viii molecules. | |
MY153964A (en) | Process for the production of water and solvent-free polymers | |
BR112014015909A2 (en) | composition | |
WO2010136585A3 (en) | Combination of adrenergic receptor agonist -1 or -2, preferably brimonidine with fillers, preferablyhyaluronic acid | |
MX344246B (en) | Method for producing 5-fluorine-1-alkyl-3-fluoralkyl-1h-pyrazol-4 carbolic acid chlorides. | |
FR2932488B1 (en) | CIPO - Patent - 2581626 Canadian Intellectual Property Office Symbol of the Government of Canada CA 2461392 STARCH - BASED THERMOPLASTIC OR ELASTOMERIC COMPOSITIONS AND PROCESS FOR THE PREPARATION OF SUCH COMPOSITIONS. | |
TW201129381A (en) | Antibodies against human CSF-1R and uses thereof | |
UA109435C2 (en) | STABILIZED AGRICULTURAL OIL DISPERSIONS | |
MY148574A (en) | Indolinone derivatives and process for their manufacture | |
WO2012059873A3 (en) | Anti-diabetic compounds | |
WO2011090949A3 (en) | Methods and compositions for processing chemical reactions | |
IN2012DN00775A (en) | ||
MX2009008660A (en) | Method for the preparation of therapeutically valuable triphenylbutene derivatives. | |
IN2012DN02804A (en) | ||
BRPI0923583A2 (en) | synthesis of polymer conjugates of indocarbzole compounds. | |
WO2013186632A3 (en) | Conjugates of biologically active molecules to functionalized polymers | |
BRPI0910383A2 (en) | polyurethane and / or ammonium polycarboanth compounds | |
WO2012092595A3 (en) | Coupled polymers and methods for making same | |
MX2012006834A (en) | Controlled synthesis of polyglutamic acid. | |
GB0912160D0 (en) | Polymer modified macromolecules | |
WO2011107967A3 (en) | Improved polymer membranes, processes for production thereof and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |